Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  MEDNAX Inc    MD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales1 8172 1542 4392 7993 1403 360
Operating income (EBITDA)420492559627707747
Operating profit (EBIT)390452513562632691
Pre-Tax Profit (EBT)388448----
Net income241281317339380417
PER---22,620,118,6
EPS ( $)2,432,783,183,614,064,39
Dividend per Share ( $)------
Yield------
Announcement Date01/31/2013
11:00am
01/30/2014
11:00am
01/29/2015
11:00am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt116-5151 185952-
Finance-10,4----
Operating income (EBITDA)420492559627707747
Leverage
(Debt/EBITDA)
0,28x-0,92x1,89x1,35x-
Capital Expenditure14,515,618,125,627,325,0
Book Value Per Share (BVPS)20,3 $23,2 $22,6 $25,2 $28,3 $-
Cash Flow per Share3,28 $4,02 $4,23 $4,41 $5,65 $-
Announcement Date01/31/2013
11:00am
01/30/2014
11:00am
01/29/2015
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 7 674 M$ -
Entreprise Value (EV) 8 859 M$ 8 626 M$
Valuation 2015e 2016e
PER (Price / EPS) 22,6x 20,1x
Capitalization / Revenue 2,74x 2,44x
EV / Revenue 3,16x 2,75x
EV / EBITDA 14,1x 12,2x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 3,24x 2,88x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 20,1% 20,1%
operating Leverage (Delta EBIT / Delta Sales) 0,64x 1,03x
Net Margin (Net Profit / Revenue) 12,1% 12,1%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 14,5% -
Rate of Dividend - -
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   0,91% 0,87%
Cash Flow / Sales (Taux d'autofinancement) 14,8% 16,9%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 1,89x 1,35x
Price Earning Ratio
EPS & Dividend